Evidence map›Paper›PMID 31846480›Full record

ArticlePloS one2019

Primary Epstein-Barr virus infection with and without infectious mononucleosis.

Klaus Rostgaard, Henry H Balfour, Ruth Jarrett, Christian Erikstrup, Ole Pedersen, Henrik Ullum, Lars Peter Nielsen, Marianne Voldstedlund, Henrik Hjalgrim

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 153 citations in OpenAlex.

  1. Trial
  2. Sex- and age-specific incidence and fraction of hospital contacts for infectious mononucleosis cases in Denmark in 1977-2011.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Adoptive T-cell therapy for virus-associated diseases.Clinical microbiology reviews · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Klaus RostgaardDepartment of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0001-6220-9414
Henry H BalfourDepartment of Laboratory Medicine and Pathology, University of Minnesota Medical Center, Minneapolis, MN, United States of America.
Ruth JarrettMRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.
Christian ErikstrupDepartment of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Ole PedersenDepartment of Clinical Immunology, Næstved Hospital, Næstved, Denmark.ORCID 0000-0003-2312-5976
Henrik UllumDepartment of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.ORCID 0000-0001-7306-9058
Lars Peter NielsenDanish National Biobank, Statens Serum Institut, Copenhagen, Denmark.
Marianne VoldstedlundDepartment of Infectious Epidemiology, Statens Serum Institut, Copenhagen, Denmark.
Henrik HjalgrimDepartment of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Statens Serum Institut · DKAarhus University Hospital · DKCopenhagen University Hospital · DKMRC University of Glasgow Centre for Virus Research · GBNæstved Sygehus · DKUniversity of Minnesota Medical Center · US

Funding

Medical Research Council MC_UU_12014/3
6 · The paper itself

Abstract

backgroundInfectious mononucleosis (IM) is a common adverse presentation of primary infection with Epstein-Barr virus (EBV) in adolescence and later, but is rarely recognized in early childhood where primary EBV infection commonly occurs. It is not known what triggers IM, and also not why IM risk upon primary EBV infection (IM attack rate) seemingly varies between children and adolescents. IM symptoms may be severe and persist for a long time. IM also markedly elevates the risk of Hodgkin lymphoma and multiple sclerosis for unknown reasons. The way IM occurrence depends on age and sex is incompletely described and hard to interpret etiologically, because it depends on three quantities that are not readily observable: the prevalence of EBV-naϊve persons, the hazard rate of seroconverting and the attack rate, i.e. the fraction of primary EBV infections that is accompanied by IM. We therefore aimed to provide these quantities indirectly, to obtain epidemiologically interpretable measures of the dynamics of IM occurrence to provide etiological clues. METHODS AND

findingsWe used joint modeling of EBV prevalence and IM occurrence data to provide detailed sex- and age-specific EBV infection rates and IM attack rates and derivatives thereof for a target population of all Danes age 0-29 years in 2006-2011. We demonstrate for the first time that IM attack rates increase dramatically rather precisely in conjunction to typical ages of puberty onset. The shape of the seroconversion hazard rate for children and teenagers confirmed a priori expectations and underlined the importance of what happens at age 0-2 years. The cumulative risk of IM before age 30 years was 13.3% for males and 22.4% for females. IM is likely to become more common through delaying EBV infection in years to come.

conclusionsThe change in attack rate at typical ages of puberty onset suggests that the immunologic response to EBV drastically changes over a relatively short age-span. We speculate that these changes are an integrated part of normal sexual maturation. Our findings may inform further etiologic research into EBV-related diseases and vaccine design. Our methodology is applicable to the epidemiological study of any infectious agent that establishes a persistent infection in the host and the sequelae thereof.

Indexed as

AdultChildChild, PreschoolEpstein-Barr Virus InfectionsFemaleHumansInfantInfant, NewbornInfectious MononucleosisMaleRisk FactorsYoung Adult

Identifiers

PMID31846480
PMCPMC6917282
OpenAlexW2996538150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.